The Deen's List Vol.6 #301

The Deen's List^TM

Our Goal: To outperform the S&P through up markets and down.

A service of Deen Capital Management, Inc. (www.deencapital.com)

Vol.6 #301 Wednesday, September 17, 2008 3:55PM EDT

Please read carefully our disclaimers at the end of this newsletter.

Market Stance: BEARISH (since September 4, 2008)

Contents

Performance
Sold DXP Enterprises, Inc. (DXPE) -4.5%
Sold Questcor Pharmaceuticals, Inc. (QCOR) -6.7%
Open Positions
Subscription Information
Privacy Policy
Disclaimers
Contact Us

Performance

Deen Capital S&P 500

Year-to-date as of September 16, 2008 -13.8% * -16.1%

12 months (Sep 16, 2007 to Sep 16, 2008) -7.3% * -16.6%

* An average of managed accounts, net after all commissions and fees.

Click here for more performance data.

Click here for information on managed accounts.

Sold DXP Enterprises, Inc. (DXPE) -4.5%

Net sell price in managed accounts* $57.66

Date(s) bought Sep 8 2008

Net buy price in managed accounts* $60.40

Holding period 1.3 weeks

Gain/loss in managed accounts* -4.5% (after commissions)

* Buy and sell prices shown are net after commissions and fees. This means that the gain/loss shown is also net after transaction expenses.

Today, Wednesday, September 17, 2008, I sold DXPE, first for client accounts, then for my personal accounts.

This is a judgment call. I chose to sell today because the stock chart looks toppy. And, of course, because I like cash right now with the market in free-fall.

-KD, Wednesday, September 17, 2008

Sold Questcor Pharmaceuticals, Inc. (QCOR) -6.7%

Net sell price in managed accounts* $5.78

Date(s) bought Sep 11 2008

Net buy price in managed accounts* $6.19

Holding period 0.9 weeks

Gain/loss in managed accounts* -6.7% (after commissions)

* Buy and sell prices shown are net after commissions and fees. This means that the gain/loss shown is also net after transaction expenses.

Today, Wednesday, September 17, 2008, I sold QCOR, first for client accounts, then for my personal accounts.

The stock is trading below my stop-loss price of $5.90 in the final 20 minutes today. Reason enough to sell.

-KD, Wednesday, September 17, 2008

Open Positions

Model Portfolio

Company Name Stock
Symbol Buy
Date NetBuy
Price* Current
Price** Weeks
Held % of
Portfolio Gain
(Loss)

Estee Lauder Cos Inc. EL 08/18/08 $51.31 $50.61 4.3 5.2% -1.4%

Thoratec Corp. THOR 08/05/08 $23.18 $26.93 6.1 7.3% +16.2%

Covidien, Ltd. COV 08/05/08 $52.60 $55.01 6.1 6.5% +4.6%

Varian Medical Systems VAR 07/24/08 $59.79 $59.87 7.9 6.5% +0.1%

Cash 74.5%

Total 100%

* Buy prices shown are net after commissions and fees.

** Current prices are at least 20 minutes old.

Subscription Information

Welcome to The Deen's List^TM, an e-mail stock newsletter from Deen Capital Management, Inc.

My intention is to inform you as quickly as is practical regarding my stock market moves. When I buy or sell a stock, first I take care of client accounts, then I buy/sell for my personal account(s), and then, third, I send out this newsletter.

Your feedback is welcome. Send e-mail to deenslist@deencapital.com. To subscribe or unsubscribe, include the word "subscribe" or "unsubscribe" in the Subject line.

This newsletter is free to managed account clients. For a limited time, it is also free to all interested parties.

Your personal information, including your e-mail address, will be held in strict confidence by Deen Capital Management, Inc. We will not share it with or sell it to others.

Disclaimers

All stocks discussed in The Deen's List^TM involve a high degree of risk. It should not be assumed that any stock discussed in The Deen's List^TM or purchased by Deen Capital Management, Inc. will be profitable.

Past performance is not necessarily indicative of future results.

The information contained herein has been compiled from sources deemed to be reliable; however, we are not responsible for its accuracy or completeness.

The Deen's List
PO Box 30925
Santa Barbara, CA 93130
(800) 353-4990
deenslist@deencapital.com